These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15179440)

  • 21. Treatment of heterotopic ossification after spinal cord injury.
    Banovac K; Gonzalez F; Renfree KJ
    J Spinal Cord Med; 1997 Jan; 20(1):60-5. PubMed ID: 9097258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans.
    Schwartz JI; Chan CC; Mukhopadhyay S; McBride KJ; Jones TM; Adcock S; Moritz C; Hedges J; Grasing K; Dobratz D; Cohen RA; Davidson MH; Bachmann KA; Gertz BJ
    Clin Pharmacol Ther; 1999 Jun; 65(6):653-60. PubMed ID: 10391671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model.
    Sycha T; Anzenhofer S; Lehr S; Schmetterer L; Chizh B; Eichler HG; Gustorff B
    Pain; 2005 Feb; 113(3):316-322. PubMed ID: 15661439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.
    Ploumis A; Donovan JM; Olurinde MO; Clark DM; Wu JC; Sohn DJ; O'Connor KC
    J Spinal Cord Med; 2015 Mar; 38(2):193-8. PubMed ID: 24820653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
    Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
    Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
    Gibofsky A; Williams GW; McKenna F; Fort JG
    Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for heterotopic ossification in patients with spinal cord injury: a case-control study of 264 patients.
    Citak M; Suero EM; Backhaus M; Aach M; Godry H; Meindl R; Schildhauer TA
    Spine (Phila Pa 1976); 2012 Nov; 37(23):1953-7. PubMed ID: 22614800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rofecoxib 50 mg and valdecoxib 20 or 40 mg in adults and adolescents with postoperative pain after third molar extraction: results of two randomized, double-blind, placebo-controlled, single-dose studies.
    Daniels SE; Desjardins PJ; Bird SR; Smugar SS; Tershakovec AM
    Clin Ther; 2006 Jul; 28(7):1022-34. PubMed ID: 16990080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of oral rofecoxib versus intravenous ketoprofen as an adjuvant to PCA morphine after urologic surgery.
    Cabrera MC; Schmied S; Derderian T; White PF; Vega R; Santelices E; Verdugo F
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1190-3. PubMed ID: 15352968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous disodium etidronate therapy in spinal cord injury patients with heterotopic ossification.
    Banovac K; Gonzalez F; Wade N; Bowker JJ
    Paraplegia; 1993 Oct; 31(10):660-6. PubMed ID: 8259329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining paracetamol with a selective cyclooxygenase-2 inhibitor for acute pain relief after third molar surgery: a randomized, double-blind, placebo-controlled study.
    Haglund B; von Bültzingslöwen I
    Eur J Oral Sci; 2006 Aug; 114(4):293-301. PubMed ID: 16911100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: a randomized, controlled trial.
    Morrison BW; Christensen S; Yuan W; Brown J; Amlani S; Seidenberg B
    Clin Ther; 1999 Jun; 21(6):943-53. PubMed ID: 10440619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
    Kivitz AJ; Greenwald MW; Cohen SB; Polis AB; Najarian DK; Dixon ME; Moidel RA; Green JA; Baraf HS; Petruschke RA; Matsumoto AK; Geba GP;
    J Am Geriatr Soc; 2004 May; 52(5):666-74. PubMed ID: 15086644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of nonsteroidal anti-inflammatory drugs to prevent heterotopic ossification after spinal cord injury: a retrospective chart review.
    Zakrasek EC; Yurkiewicz SM; Dirlikov B; Pence BT; Crew JD
    Spinal Cord; 2019 Mar; 57(3):214-220. PubMed ID: 30254206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase-2 specific inhibitors and upper gastrointestinal tolerability in patients with osteoarthritis receiving concomitant low dose aspirin: pooled analysis of 2 trials.
    Goldstein JL; Bello AE; Spalding W; Suh S; Fort JG
    J Rheumatol; 2005 Jan; 32(1):111-7. PubMed ID: 15630735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
    Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
    Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind prospective comparison of rofecoxib vs ketorolac in reducing postoperative pain after arthroscopic knee surgery.
    Kim JT; Sherman O; Cuff G; Leibovits A; Wajda M; Bekker AY
    J Clin Anesth; 2005 Sep; 17(6):439-43. PubMed ID: 16171664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does perioperative administration of rofecoxib improve analgesia after spine, breast and orthopaedic surgery?
    Riest G; Peters J; Weiss M; Pospiech J; Hoffmann O; Neuhäuser M; Beiderlinden M; Eikermann M
    Eur J Anaesthesiol; 2006 Mar; 23(3):219-26. PubMed ID: 16430794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 4-aminopyridine on gait in ambulatory spinal cord injuries: a double-blind, placebo-controlled, crossover trial.
    DeForge D; Nymark J; Lemaire E; Gardner S; Hunt M; Martel L; Curran D; Barbeau H
    Spinal Cord; 2004 Dec; 42(12):674-85. PubMed ID: 15356676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.